Download PDF
Semin Musculoskelet Radiol 2012; 16(05): 377-388
DOI: 10.1055/s-0032-1329881
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Whole-Body MRI for Inflammatory Arthritis and Other Multifocal Rheumatoid Diseases

Sabine Weckbach
1   Institute for Clinical Radiology, Ludwig-Maximilians-University Hospital Munich, Munich, Germany
2   Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany
› Author Affiliations
Further Information

Publication History

Publication Date:
04 December 2012 (online)

Also available at
    Permissions and Reprints

Abstract

Whole-body MRI (WBMRI) is an excellent tool for the imaging of rheumatologic diseases with a multifocal and systemic character. These include the different forms of spondyloarthritis, chronic recurrent multifocal osteomyelitis (CRMO), and inflammatory muscle diseases along with diseases such as systemic lupus and systemic sclerosis that show organ involvement. Although it is not recommended as a first-line investigation in every patient, it may add important information in difficult cases.

Currently WBMRI for inflammatory arthritis is mainly used in imaging the seronegative spondyloarthropathies. The technique visualizes most of the involved joints and soft tissue structures with both (early) active and chronic inflammatory changes in one examination. Different patterns of joint involvement can be recognized, with both the acute features of the disease and the longer term sequelae being shown. The technique also allows therapeutic response to be assessed.

In CRMO, WBMRI is able to detect asymptomatic and radiographically occult multifocal lesions that typically show a symmetrical distribution predominating in the lower extremity.

In inflammatory muscle diseases, WBMRI is able to provide important information for biochemical and genetic differential diagnosis because there is growing knowledge of the correlation between typical patterns of disease and defined clinical entities. In addition, it helps in biopsy localization and is very well suited for assessing disease activity.

WBMRI is particularly useful for studying internal organ involvement, especially the brain, heart, and lungs in connective tissue diseases such as systemic lupus erythematosus in one whole-body exam.

Keywords

whole-body MRI - inflammatory arthritis - ankylosing spondylitis - CRMO - inflammatory myopathy - MR protocol - multifocal disease
 

  • References

  • 1 Lenk S, Fischer S, Kötter I, Claussen CD, Schlemmer HP. Possibilities of whole-body MRI for investigating musculoskeletal diseases. [in German]. Radiologe 2004; 44 (9) 844-853
    PubMedGoogle Scholar
  • 2 Schmidt GP, Reiser MF, Baur-Melnyk A. Whole-body imaging of the musculoskeletal system: the value of MR imaging. Skeletal Radiol 2007; 36 (12) 1109-1119
    CrossrefPubMedGoogle Scholar
  • 3 Schmidt GP, Schoenberg SO, Reiser MF, Baur-Melnyk A. Whole-body MR imaging of bone marrow. Eur J Radiol 2005; 55 (1) 33-40
    CrossrefPubMedGoogle Scholar
  • 4 Baur-Melnyk A, Buhmann S, Becker C , et al. Whole-body MRI versus whole-body MDCT for staging of multiple myeloma. AJR Am J Roentgenol 2008; 190 (4) 1097-1104
    CrossrefPubMedGoogle Scholar
  • 5 Dinter DJ, Neff WK, Klaus J , et al. Comparison of whole-body MR imaging and conventional X-ray examination in patients with multiple myeloma and implications for therapy. Ann Hematol 2009; 88 (5) 457-464
    CrossrefPubMedGoogle Scholar
  • 6 Leroy-Willig A. Quantitative MR evaluation of body composition in patients with Duchenne muscular dystrophy. Eur Radiol 2003; 13 (12) 2710-2711; author reply 2712
    CrossrefPubMedGoogle Scholar
  • 7 Pichiecchio A, Uggetti C, Egitto MG , et al. Quantitative MR evaluation of body composition in patients with Duchenne muscular dystrophy. Eur Radiol 2002; 12 (11) 2704-2709
    PubMedGoogle Scholar
  • 8 Schramm N, Born C, Weckbach S, Reilich P, Walter MC, Reiser MF. Involvement patterns in myotilinopathy and desminopathy detected by a novel neuromuscular whole-body MRI protocol. Eur Radiol 2008; 18 (12) 2922-2936
    CrossrefPubMedGoogle Scholar
  • 9 Healy PJ, Helliwell PS. Classification of the spondyloarthropathies. Curr Opin Rheumatol 2005; 17 (4) 395-399
    CrossrefPubMedGoogle Scholar
  • 10 Braun J, Bollow M, Sieper J. Radiologic diagnosis and pathology of the spondyloarthropathies. Rheum Dis Clin North Am 1998; 24 (4) 697-735
    CrossrefPubMedGoogle Scholar
  • 11 Akgul O, Ozgocmen S. Classification criteria for spondyloarthropathies. World J Orthod 2011; 2 (12) 107-115
    CrossrefPubMedGoogle Scholar
  • 12 Van den Bosch F, Cryssen BV, Mielants H. Clinical assessment in the spondyloarthropathies, including psoriatic arthritis. Curr Opin Rheumatol 2006; 18 (4) 354-358
    CrossrefPubMedGoogle Scholar
  • 13 Nash P, Mease PJ, Braun J, van der Heijde D. Seronegative spondyloarthropathies: to lump or split?. Ann Rheum Dis 2005; 64 (Suppl. 02) ii9-ii13
    CrossrefPubMedGoogle Scholar
  • 14 Chatzikyriakidou A, Voulgari PV, Drosos AA. What is the role of HLA-B27 in spondyloarthropathies?. Autoimmun Rev 2011; 10 (8) 464-468
    CrossrefPubMedGoogle Scholar
  • 15 Khan MA. Newer clinical and radiographic features of seronegative spondyloarthropathies. Curr Opin Rheumatol 1989; 1 (2) 139-143
    CrossrefPubMedGoogle Scholar
  • 16 Eshed I, Bollow M, McGonagle DG , et al. MRI of enthesitis of the appendicular skeleton in spondyloarthritis. Ann Rheum Dis 2007; 66 (12) 1553-1559
    CrossrefPubMedGoogle Scholar
  • 17 Zochling J, Baraliakos X, Hermann KG, Braun J. Magnetic resonance imaging in ankylosing spondylitis. Curr Opin Rheumatol 2007; 19 (4) 346-352
    CrossrefPubMedGoogle Scholar
  • 18 Krueger JG, Bowcock A. Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis 2005; 64 (Suppl. 02) ii30-ii36
    CrossrefPubMedGoogle Scholar
  • 19 McGonagle D. Imaging the joint and enthesis: insights into pathogenesis of psoriatic arthritis. Ann Rheum Dis 2005; 64 (Suppl. 02) ii58-ii60
    CrossrefPubMedGoogle Scholar
  • 20 McQueen F, Lassere M, Østergaard M. Magnetic resonance imaging in psoriatic arthritis: a review of the literature. Arthritis Res Ther 2006; 8 (2) 207
    CrossrefPubMedGoogle Scholar
  • 21 Jevtic V, Watt I, Rozman B, Kos-Golja M, Demsar F, Jarh O. Distinctive radiological features of small hand joints in rheumatoid arthritis and seronegative spondyloarthritis demonstrated by contrast-enhanced (Gd-DTPA) magnetic resonance imaging. Skeletal Radiol 1995; 24 (5) 351-355
    PubMedGoogle Scholar
  • 22 Becker H, Gaubitz M, Domschke W, Kucharzik T. Joint involvement in chronic inflammatory bowel disease—current diagnostics and treatment options. [in German]. Z Gastroenterol 2006; 44 (6) 497-502
    Article in Thieme ConnectPubMedGoogle Scholar
  • 23 Fries W. Inflammatory bowel disease-associated spondyloarthropathies. World J Gastroenterol 2009; 15 (20) 2441-2442
    CrossrefPubMedGoogle Scholar
  • 24 Resnick D. Radiology of seronegative spondyloarthropathies. Clin Orthop Relat Res 1979; (143) 38-45
    PubMedGoogle Scholar
  • 25 Kettering JM, Towers JD, Rubin DA. The seronegative spondyloarthropathies. Semin Roentgenol 1996; 31 (3) 220-228
    CrossrefPubMedGoogle Scholar
  • 26 Jevtic V, Rozman B, Kos-Golja M, Watt I. MR imaging in seronegative spondyloarthritis. [in German]. Radiologe 1996; 36 (8) 624-631
    CrossrefPubMedGoogle Scholar
  • 27 Braun J, Sieper J, Breban M , et al. Anti-tumour necrosis factor alpha therapy for ankylosing spondylitis: international experience. Ann Rheum Dis 2002; 61 (Suppl. 03) iii51-iii60
    PubMedGoogle Scholar
  • 28 Braun J, Bollow M, Remlinger G , et al. Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 1998; 41 (1) 58-67
    CrossrefPubMedGoogle Scholar
  • 29 Aggarwal R, Malaviya AN. Diagnosis delay in patients with ankylosing spondylitis: factors and outcomes—an Indian perspective. Clin Rheumatol 2009; 28 (3) 327-331
    CrossrefPubMedGoogle Scholar
  • 30 Dincer U, Cakar E, Kiralp MZ, Dursun H. Diagnosis delay in patients with ankylosing spondylitis: possible reasons and proposals for new diagnostic criteria. Clin Rheumatol 2008; 27 (4) 457-462
    CrossrefPubMedGoogle Scholar
  • 31 Muche B, Bollow M, François RJ, Sieper J, Hamm B, Braun J. Anatomic structures involved in early- and late-stage sacroiliitis in spondylarthritis: a detailed analysis by contrast-enhanced magnetic resonance imaging. Arthritis Rheum 2003; 48 (5) 1374-1384
    CrossrefPubMedGoogle Scholar
  • 32 Althoff CE, Sieper J, Song IH , et al. Active inflammation and structural change in early active axial spondyloarthritis as detected by whole-body MRI. Ann Rheum Dis 2012; ; June 26 ( Epub ahead of print)
    PubMedGoogle Scholar
  • 33 Weber U, Pfirrmann CW, Kissling RO, Hodler J, Zanetti M. Whole body MR imaging in ankylosing spondylitis: a descriptive pilot study in patients with suspected early and active confirmed ankylosing spondylitis. BMC Musculoskelet Disord 2007; 8: 20
    CrossrefPubMedGoogle Scholar
  • 34 Hermann KG, Eshed I, Bollow M. Imaging of enthesitis: a new field for the radiologist?. [in German]. Rofo 2006; 178 (6) 578-589
    Article in Thieme ConnectPubMedGoogle Scholar
  • 35 Althoff CE, Appel H, Rudwaleit M , et al. Whole-body MRI as a new screening tool for detecting axial and peripheral manifestations of spondyloarthritis. Ann Rheum Dis 2007; 66 (7) 983-985
    CrossrefPubMedGoogle Scholar
  • 36 Weckbach SMH, Schewe S, Reiser M, Glaser C. Whole-body MRI in psoriatic arthritis—development of an imaging protocol and evaluation in 25 patients. Skeletal Radiol 2007; 36: 562-563
    PubMedGoogle Scholar
  • 37 Appel H, Hermann KG, Althoff CE, Rudwaleit M, Sieper J. Whole-body magnetic resonance imaging evaluation of widespread inflammatory lesions in a patient with ankylosing spondylitis before and after 1.  year of treatment with infliximab. J Rheumatol 2007; 34 (12) 2497-2498
    PubMedGoogle Scholar
  • 38 Klauser A, De Zordo T, Feuchtner G , et al. Feasibility of ultrasound-guided sacroiliac joint injection considering sonoanatomic landmarks at two different levels in cadavers and patients. Arthritis Rheum 2008; 59 (11) 1618-1624
    CrossrefPubMedGoogle Scholar
  • 39 Klauser A, Demharter J, De Marchi A , et al; IACUS study group. Contrast enhanced gray-scale sonography in assessment of joint vascularity in rheumatoid arthritis: results from the IACUS study group. Eur Radiol 2005; 15 (12) 2404-2410
    CrossrefPubMedGoogle Scholar
  • 40 Ghanem N, Uhl M, Pache G, Bley T, Walker UA, Langer M. MRI in psoriatic arthritis with hand and foot involvement. Rheumatol Int 2007; 27 (4) 387-393
    CrossrefPubMedGoogle Scholar
  • 41 Bollow M, Fischer T, Reisshauer H , et al. Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis—cellularity correlates with the degree of enhancement detected by magnetic resonance imaging. Ann Rheum Dis 2000; 59 (2) 135-140
    CrossrefPubMedGoogle Scholar
  • 42 Bredella MA, Steinbach LS, Morgan S, Ward M, Davis JC. MRI of the sacroiliac joints in patients with moderate to severe ankylosing spondylitis. AJR Am J Roentgenol 2006; 187 (6) 1420-1426
    CrossrefPubMedGoogle Scholar
  • 43 Hermann KG, Landewé RB, Braun J, van der Heijde DM. Magnetic resonance imaging of inflammatory lesions in the spine in ankylosing spondylitis clinical trials: is paramagnetic contrast medium necessary?. J Rheumatol 2005; 32 (10) 2056-2060
    PubMedGoogle Scholar
  • 44 Ory PA, Gladman DD, Mease PJ. Psoriatic arthritis and imaging. Ann Rheum Dis 2005; 64 (Suppl. 02) ii55-ii57
    CrossrefPubMedGoogle Scholar
  • 45 Hermann KG, Braun J, Fischer T, Reisshauer H, Bollow M. Magnetic resonance tomography of sacroiliitis: anatomy, histological pathology, MR-morphology, and grading. [in German]. Radiologe 2004; 44 (3) 217-228
    CrossrefPubMedGoogle Scholar
  • 46 Darge K, Jaramillo D, Siegel MJ. Whole-body MRI in children: current status and future applications. Eur J Radiol 2008; 68 (2) 289-298
    Google Scholar
  • 47 Sundaram M, McDonald D, Engel E, Rotman M, Siegfried EC. Chronic recurrent multifocal osteomyelitis: an evolving clinical and radiological spectrum. Skeletal Radiol 1996; 25 (4) 333-336
    CrossrefPubMedGoogle Scholar
  • 48 Ferguson PJ, Sandu M. Current understanding of the pathogenesis and management of chronic recurrent multifocal osteomyelitis. Curr Rheumatol Rep 2012; 14 (2) 130-141
    CrossrefPubMedGoogle Scholar
  • 49 Jurik AG. Chronic recurrent multifocal osteomyelitis. Semin Musculoskelet Radiol 2004; 8 (3) 243-253
    Article in Thieme ConnectPubMedGoogle Scholar
  • 50 Fritz J, Tzaribatchev N, Claussen CD, Carrino JA, Horger MS. Chronic recurrent multifocal osteomyelitis: comparison of whole-body MR imaging with radiography and correlation with clinical and laboratory data. Radiology 2009; 252 (3) 842-851
    CrossrefPubMedGoogle Scholar
  • 51 Guérin-Pfyffer S, Guillaume-Czitrom S, Tammam S, Koné-Paut I. Evaluation of chronic recurrent multifocal osteitis in children by whole-body magnetic resonance imaging. Joint Bone Spine 2012; ; January 25 ( Epub ahead of print)
    PubMedGoogle Scholar
  • 52 Amato AA, Barohn RJ. Inclusion body myositis: old and new concepts. J Neurol Neurosurg Psychiatry 2009; 80 (11) 1186-1193
    CrossrefPubMedGoogle Scholar
  • 53 Dalakas MC. Review: An update on inflammatory and autoimmune myopathies. Neuropathol Appl Neurobiol 2011; 37 (3) 226-242
    CrossrefPubMedGoogle Scholar
  • 54 Dalakas MC. Inflammatory muscle diseases: a critical review on pathogenesis and therapies. Curr Opin Pharmacol 2010; 10 (3) 346-352
    CrossrefPubMedGoogle Scholar
  • 55 Dimitri D, Eymard B. Inflammatory myopathies, autoimmune necrotizing myopathies and adult-onset genetic myopathies: differential diagnosis. [in French]. Rev Med Interne 2012; 33 (3) 134-142
    CrossrefPubMedGoogle Scholar
  • 56 Dalakas MC. Pathogenesis and therapies of immune-mediated myopathies. Autoimmun Rev 2012; 11 (3) 203-206
    CrossrefPubMedGoogle Scholar
  • 57 Greenberg SA. Inflammatory myopathies: evaluation and management. Semin Neurol 2008; 28 (2) 241-249
    Article in Thieme ConnectPubMedGoogle Scholar
  • 58 May DA, Disler DG, Jones EA, Balkissoon AA, Manaster BJ. Abnormal signal intensity in skeletal muscle at MR imaging: patterns, pearls, and pitfalls. Radiographics 2000; 20 (Spec No) S295-S315
    PubMedGoogle Scholar
  • 59 Schulze M, Kötter I, Ernemann U , et al. MRI findings in inflammatory muscle diseases and their noninflammatory mimics. AJR Am J Roentgenol 2009; 192 (6) 1708-1716
    CrossrefPubMedGoogle Scholar
  • 60 Peters SA, Köhler C, Schara U , et al. Muscular magnetic resonance imaging for evaluation of myopathies in children. [in German]. Klin Padiatr 2008; 220 (1) 37-46
    Article in Thieme ConnectPubMedGoogle Scholar
  • 61 Mercuri E, Bushby K, Ricci E , et al. Muscle MRI findings in patients with limb girdle muscular dystrophy with calpain 3 deficiency (LGMD2A) and early contractures. Neuromuscul Disord 2005; 15 (2) 164-171
    CrossrefPubMedGoogle Scholar
  • 62 Mercuri E, Jungbluth H, Muntoni F. Muscle imaging in clinical practice: diagnostic value of muscle magnetic resonance imaging in inherited neuromuscular disorders. Curr Opin Neurol 2005; 18 (5) 526-537
    CrossrefPubMedGoogle Scholar
  • 63 Mercuri E, Pichiecchio A, Allsop J, Messina S, Pane M, Muntoni F. Muscle MRI in inherited neuromuscular disorders: past, present, and future. J Magn Reson Imaging 2007; 25 (2) 433-440
    CrossrefPubMedGoogle Scholar
  • 64 Mercuri E, Pichiecchio A, Counsell S , et al. A short protocol for muscle MRI in children with muscular dystrophies. Eur J Paediatr Neurol 2002; 6 (6) 305-307
    CrossrefPubMedGoogle Scholar
  • 65 O'Connell MJ, Powell T, Brennan D, Lynch T, McCarthy CJ, Eustace SJ. Whole-body MR imaging in the diagnosis of polymyositis. AJR Am J Roentgenol 2002; 179 (4) 967-971
    CrossrefPubMedGoogle Scholar
  • 66 Kornblum C, Lutterbey G, Bogdanow M , et al. Distinct neuromuscular phenotypes in myotonic dystrophy types 1 and 2: a whole body highfield MRI study. J Neurol 2006; 253 (6) 753-761
    CrossrefPubMedGoogle Scholar
  • 67 Tzaribachev N, Well C, Schedel J, Horger M. Whole-body MRI: a helpful diagnostic tool for juvenile dermatomyositis case report and review of the literature. Rheumatol Int 2009; 29 (12) 1511-1514
    CrossrefPubMedGoogle Scholar
  • 68 Ozsarlak O, Parizel PM, De Schepper AM, De Jonghe P, Martin JJ. Whole-body MR screening of muscles in the evaluation of neuromuscular diseases. Eur Radiol 2004; 14 (8) 1489-1493
    PubMedGoogle Scholar
  • 69 Fischer D, Walter MC, Kesper K , et al. Diagnostic value of muscle MRI in differentiating LGMD2I from other LGMDs. J Neurol 2005; 252 (5) 538-547
    CrossrefPubMedGoogle Scholar
  • 70 Connor A, Stebbings S, Anne Hung N, Hammond-Tooke G, Meikle G, Highton J. STIR MRI to direct muscle biopsy in suspected idiopathic inflammatory myopathy. J Clin Rheumatol 2007; 13 (6) 341-345
    CrossrefPubMedGoogle Scholar
  • 71 Cronin ME. Musculoskeletal manifestations of systemic lupus erythematosus. Rheum Dis Clin North Am 1988; 14 (1) 99-116
    PubMedGoogle Scholar
  • 72 Ball EM, Bell AL. Lupus arthritis—do we have a clinically useful classification?. Rheumatology (Oxford) 2012; 51 (5) 771-779
    CrossrefPubMedGoogle Scholar
  • 73 Rueda JC, Duque MA, Mantilla RD, Iglesias-Gamarra A. Osteonecrosis and antiphospholipid syndrome. J Clin Rheumatol 2009; 15 (3) 130-132
    CrossrefPubMedGoogle Scholar
  • 74 Oh SN, Jee WH, Cho SM , et al. Osteonecrosis in patients with systemic lupus erythematosus: MR imaging and scintigraphic evaluation. Clin Imaging 2004; 28 (4) 305-309
    CrossrefPubMedGoogle Scholar
  • 75 Abu-Shakra M, Buskila D, Shoenfeld Y. Osteonecrosis in patients with SLE. Clin Rev Allergy Immunol 2003; 25 (1) 13-24
    CrossrefPubMedGoogle Scholar
  • 76 Aranow C, Zelicof S, Leslie D , et al. Clinically occult avascular necrosis of the hip in systemic lupus erythematosus. J Rheumatol 1997; 24 (12) 2318-2322
    PubMedGoogle Scholar
  • 77 Salesi M, Karimifar M, Mottaghi P, Sayedbonakdar Z, Karimzadeh H. A case of SLE with bilateral osteonecrosis of femoral heads and bone infarct in distal of femur. Rheumatol Int 2010; 30 (4) 527-529
    CrossrefPubMedGoogle Scholar
  • 78 Doria A, Iaccarino L, Sarzi-Puttini P, Atzeni F, Turriel M, Petri M. Cardiac involvement in systemic lupus erythematosus. Lupus 2005; 14 (9) 683-686
    CrossrefPubMedGoogle Scholar
  • 79 Riboldi P, Gerosa M, Luzzana C, Catelli L. Cardiac involvement in systemic autoimmune diseases. Clin Rev Allergy Immunol 2002; 23 (3) 247-261
    CrossrefPubMedGoogle Scholar
  • 80 Lalani TA, Kanne JP, Hatfield GA, Chen P. Imaging findings in systemic lupus erythematosus. Radiographics 2004; 24 (4) 1069-1086
    CrossrefPubMedGoogle Scholar
  • 81 Castro TC, Lederman H, Terreri MT, Caldana WI, Kaste SC, Hilário MO. The use of joint-specific and whole-body MRI in osteonecrosis: a study in patients with juvenile systemic lupus erythematosus. Br J Radiol 2011; 84 (1003) 621-628
    CrossrefPubMedGoogle Scholar
  • 82 Singh JA, Woodard PK, Dávila-Román VG , et al. Cardiac magnetic resonance imaging abnormalities in systemic lupus erythematosus: a preliminary report. Lupus 2005; 14 (2) 137-144
    CrossrefPubMedGoogle Scholar
  • 83 O'Neill SG, Woldman S, Bailliard F , et al. Cardiac magnetic resonance imaging in patients with systemic lupus erythematosus. Ann Rheum Dis 2009; 68 (9) 1478-1481
    CrossrefPubMedGoogle Scholar